Featured Post

Twenty Practical Steps to Better Corporate Governance | The Corporate Secretaries International Association (CSIA)

Twenty Practical Steps to Better Corporate Governance | The Corporate Secretaries International Association (CSIA) Please click the li...

Monday, April 3, 2017

Cydan Development Announces the Acquisition of Its First Rare Disease Spin-out, Vtesse, Inc. by Sucampo Pharmaceuticals, Inc.

http://ift.tt/eA8V8J
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cydan today announces that Vtesse, Inc., its first rare disease spin-out company, has been acquired by Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP).

April 03, 2017 at 07:31PM

http://ift.tt/2oQwJIW

from

http://ift.tt/2oQwJIW
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)